Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 27.213.421.83-18.5822.20

What is the latest EV/EBIT ratio of SOTAC PHARMACEUTICALS ?

The latest EV/EBIT ratio of SOTAC PHARMACEUTICALS is 27.21 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202427.21
Mar20233.42
Mar20221.83
Mar2021-18.58
Mar202022.20

How is EV/EBIT of SOTAC PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 27.21
695.61
Mar2023 3.42
86.89
Mar2022 1.83
Positive
Mar2021 -18.58
Negative
Mar2020 22.2 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EV/EBIT ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹121.5 Cr -1.1% -20% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-1.1%

-20%

-8.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses